Pay in 4 interest-free payments of $37.19 Learn more
Ships within 48 hours · Estimated delivery Aug 3 - Aug 8
Long-term treatment of spontaneously hypertensive rats with PD123319 and electrophysiological remodeling of left ventricular myocardium
N Engl J Med
Down-regulation of RhoA is involved in the cytotoxic action of lipophilic statins in HepG2 cells
leading to their malformation and Hedgehog signaling blockade
WO 2018136700 A1 20180726
Pomalidomide HCl Long-term treatment of spontaneously hypertensivePomalidomide, also known as CC4047, is an orally bioavailable derivative of thalidomide with potential immunomodulating, antiangiogenic and antineoplastic activities. Although its exact mechanism of action has yet to be fully elucidated, pomalidomide appears to inhibit TNF alpha production, enhance the activity of T cells and natural killer (NK) cells and enhance antibody dependent cellular cytotoxicity (ADCC). Pomalidomide was approved on February 8,
US$ 149.50
US$ 149.50
US$ 79.00
US$ 2763.59
US$ 1001.08
US$ 61.66